BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23674164)

  • 1. Current Lynch syndrome tumor screening practices: a survey of genetic counselors.
    Cohen SA
    J Genet Couns; 2014 Feb; 23(1):38-47. PubMed ID: 23674164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center.
    Moline J; Mahdi H; Yang B; Biscotti C; Roma AA; Heald B; Rose PG; Michener C; Eng C
    Gynecol Oncol; 2013 Jul; 130(1):121-6. PubMed ID: 23612316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.
    Frolova AI; Babb SA; Zantow E; Hagemann AR; Powell MA; Thaker PH; Gao F; Mutch DG
    Gynecol Oncol; 2015 Apr; 137(1):7-13. PubMed ID: 25617771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic counseling and cascade genetic testing in Lynch syndrome.
    Hampel H
    Fam Cancer; 2016 Jul; 15(3):423-7. PubMed ID: 26969309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal tumor screening for Lynch syndrome: Perceptions of Canadian pathologists and genetic counselors of barriers and facilitators.
    Dicks E; Pullman D; Kao K; MacMillan A; Logan GS; Simmonds C; Etchegary H
    Cancer Med; 2019 Jul; 8(7):3614-3622. PubMed ID: 31102338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Screening With Combined Age- and Morphology-Based Criteria Enriches Detection of Lynch Syndrome in Endometrial Cancer.
    Lin DI; Hecht JL
    Int J Surg Pathol; 2016 Jun; 24(4):297-305. PubMed ID: 26842347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lynch syndrome screening in gynaecological cancers: results of an international survey with recommendations for uniform reporting terminology for mismatch repair immunohistochemistry results.
    Ryan N; Wall J; Crosbie EJ; Arends M; Bosse T; Arif S; Faruqi A; Frayling I; Ganesan R; Hock YL; McMahon R; Manchanda R; McCluggage WG; Mukonoweshuro P; van Schalkwyk G; Side L; Smith JH; Tanchel B; Evans DG; Gilks CB; Singh N
    Histopathology; 2019 Dec; 75(6):813-824. PubMed ID: 31310679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.
    Hampel H
    J Natl Compr Canc Netw; 2010 May; 8(5):597-601. PubMed ID: 20495086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.
    Holter S; Hall MJ; Hampel H; Jasperson K; Kupfer SS; Larsen Haidle J; Mork ME; Palaniapppan S; Senter L; Stoffel EM; Weissman SM; Yurgelun MB
    J Genet Couns; 2022 Jun; 31(3):568-583. PubMed ID: 35001450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
    Heald B; Plesec T; Liu X; Pai R; Patil D; Moline J; Sharp RR; Burke CA; Kalady MF; Church J; Eng C
    J Clin Oncol; 2013 Apr; 31(10):1336-40. PubMed ID: 23401454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers.
    Hunter JE; Zepp JM; Gilmore MJ; Davis JV; Esterberg EJ; Muessig KR; Peterson SK; Syngal S; Acheson LS; Wiesner GL; Reiss JA; Goddard KA
    Cancer; 2015 Sep; 121(18):3281-9. PubMed ID: 26036338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
    Schneider R; Schneider C; Büttner R; Reinacher-Schick A; Tannapfel A; Fürst A; Rüschoff J; Jakobeit C; Royer-Pokora B; Möslein G
    Zentralbl Chir; 2015 Dec; 140(6):591-9. PubMed ID: 25372301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lynch syndrome presenting as endometrial cancer.
    Tafe LJ; Riggs ER; Tsongalis GJ
    Clin Chem; 2014 Jan; 60(1):111-21. PubMed ID: 24193118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counterpoint: implementing population genetic screening for Lynch Syndrome among newly diagnosed colorectal cancer patients--will the ends justify the means?
    Hall MJ
    J Natl Compr Canc Netw; 2010 May; 8(5):606-11. PubMed ID: 20495087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
    Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers.
    Kim SR; Tone A; Kim R; Cesari M; Clarke B; Eiriksson L; Hart T; Aronson M; Holter S; Lytwyn A; Maganti M; Oldfield L; Gallinger S; Bernardini MQ; Oza AM; Djordjevic B; Lerner-Ellis J; Van de Laar E; Vicus D; Pugh TJ; Pollett A; Ferguson SE
    Int J Gynecol Cancer; 2020 Dec; 30(12):1951-1958. PubMed ID: 33082239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.